Neurotech has more companies and more funding. Most appear to be incremental improvements to the same core technologies.
What are the barriers to entry, what are the most promising up-and-coming approaches, and how can new entrants accelerate the field?
What are the barriers to entry?
- Fundamentally new neurotech requires hybrid skillsets (hardware, biology, data)
- Slow feedback loops due to the need for human testing and medical device approval
- For mental health applications, it’s hard to measure success: depression, anxiety, insomnia, etc an be caused or alleviated by other confounding variables
- Some noninvasive devices seem to work decently well for a small fraction of people, but have an overall low average effect
- People are (understandably) resistant to devices that can read or influence their brain activity, in ways they don’t understand. The Overton window of technology invasiveness: It’s acceptable to continuosly drink caffeine, and almost-normal to wear a continuous glucose monitor, but it would be unusual for someone to be eager to get an implanted Neuralink.
Neurotech can be framed as an I/O challenge
- How to record and stimulate with high spatial and temporal resolution
- Different resolutions may be useful for different applications
How can you get more I/O?
- Go invasive (i.e. Neuralink)
- Improve higher-resolution noninvasive modalities (infrared / ultrasound)
- Combine a higher number of current noninvasive modalities (US, IR, EMG, EEG)
- Low-res sensors, but more of them with more time.
- Experiment: 200 mini-EEGs embedded in the scalp to record 24/7
Approaches that deserve more exploration